NACDS Submits Comments to FDA on Expanding Access to Nonprescription Drugs
Comments emphasize the importance of coordinated policy and operational alignment to support affordable and seamless patient access.
Comments emphasize the importance of coordinated policy and operational alignment to support affordable and seamless patient access.
National pharmacy organizations warn Congress that failure to curb abusive PBM practices has escalated from an emerging threat to an unaddressed crisis for patients and pharmacies.
The inclusion of these provisions reinforces congressional commitment to advancing meaningful PBM reforms.
NBC10 Philadelphia aired a segment on the accelerating wave of pharmacy closures driven by pharmacy benefit manager (PBM) middlemen tactics.
As key panel targets healthcare costs, NACDS calls PBM reform a “win ready for the taking,” also promotes bill to boost Medicare pharmacy services.
Pharmacists ready to help Americans save more as FDA streamlines biosimilar approvals and advances interchangeability; NACDS urges Congress to finish its job on PBM reform.
Association calls for phased, strategic action to strengthen U.S. pharmaceutical manufacturing while ensuring immediate safeguards for Americans’ access to necessary medications and trusted pharmacies.
NACDS also praises Congressional engagement to prevent disruptions of patients’ access to prescription drugs through no fault of dispensers.
This situation jeopardizes patients' access to prescription drugs, through no fault of dispensers.
This campaign raises awareness about the threat of antibiotic resistance and the importance of appropriate antibiotic use.